Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The Lancet

• Publication date

  2002-07-20

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S0140-6736(02)09456-4PMID 12133654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on the macrofilarial population of Onchocerca volvulus in hyper-endemic villages of the Central province of Cameroon.

  2001cited by this paper
• Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.

  2001cited by this paper
• Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon

  2001cited by this paper
• Onchocerciasis control strategies

  2000cited by this paper
• Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis.

  2000cited by this paper
• Onchocerciasis control strategies.

  2000cited by this paper
• Programmatic goals and approaches to onchocerciasis.

  2000cited by this paper
• The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients.

  1999cited by this paper
• Onchocerciasis.

  1998cited by this paper
• Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

  1997cited by this paper
• Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments.

  1997cited by this paper
• The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin.

  1995cited by this paper
• Effects of three-month doses of ivermectin on adult Onchocerca volvulus.

  1992cited by this paper
• Viability of adult Onchocerca volvulus after six 2-weekly doses of ivermectin.

  1991cited by this paper
• On the reproductive activity of the female Onchocerca volvulus.

  1990cited by this paper
• ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis.

  1990cited by this paper
• Effect of diethylcarbamazine on adult Loa in monkeys.

  1990cited by this paper
• Effects of multiple monthly doses of ivermectin on adult Onchocerca volvulus.

  1990cited by this paper
• Diagnosis and extirpation of nodules in human onchocerciasis.

  1988cited by this paper
• Diagnosis and extirpation of nodules in human onchocerciasis.

  1988cited by this paper
• A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area.

  1986cited by this paper
• THE USE OF LOGARITHMS IN THE INTERPRETATION OF CERTAIN ENTOMOLOGICAL PROBLEMS

  1937cited by this paper

• Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review.

  2026cites this paper
• Modeling the effectiveness of Esperanza window traps as a complementary vector control strategy for achieving the community-wide elimination of onchocerciasis

  2025cites this paper
• Variations in Plasma Levels of Orally Administered Ivermectin Could Hamper Its Potential Drug Repositioning: Results of a Bioequivalence Study in Mexican Population

  2025cites this paper
• Current perspectives in the epidemiology and control of lymphatic filariasis

  2025cites this paper
• River blindness: a devastating yet neglected tropical disease in Africa

  2025cites this paper
• Appraising Onchocerciasis Community Directed Treatment with Ivermectin: Problems, Progress and Prospects

  2023cites this paper
• Progress towards the implementation of control programmes for strongyloidiasis in endemic areas: estimation of number of adults in need of ivermectin for strongyloidiasis

  2023cites this paper
• The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration

  2023cites this paper
• A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis

  2023cites this paper
• Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?

  2023cites this paper
• Drug development for onchocerciasis-the past, the present and the future

  2022cites this paper
• Leukoderma with perifollicular sparing: a diagnostic clue of cutaneous onchocerciasis

  2022cites this paper
• How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?

  2021cites this paper
• Multimodal biomarker discovery for active Onchocerca volvulus infection

  2021cites this paper
• Neglected Tropical Diseases. The Place of Ivermectin in the Elimination Programs

  2021cites this paper
• Strategies for Suppression and Elimination of Onchocerciasis in Endemic Countries: A Review of the Literature

  2021cites this paper
• Human Filariasis

  2021cites this paper
• Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon

  2021cites this paper
• Onchocerciasis drug development: from preclinical models to humans

  2021cites this paper
• Onchocerca volvulus transmission in the Mbam valley of Cameroon following 16 years of annual community-directed treatment with ivermectin, and the description of a new cytotype of Simulium squamosum

  2021cites this paper
• Atualização em dermatoses parasitárias

  2020cites this paper
• Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually

  2020cites this paper
• Ivermectin and Moxidectin Can Incapacitate Different Strains of the Common Bed Bug Cimex lectularius L.: A Study

  2020cites this paper
• Onchocerciasis and Other Parasitic Diseases

  2020cites this paper
• DRUG PROFILE Moxidectin: an oral treatment for human onchocerciasis

  2020cites this paper
• Moxidectin: an oral treatment for human onchocerciasis

  2020cites this paper
• Subjects living in an onchocerciasis focus and treated 3-monthly with ivermectin develop fewer new onchocercal nodules than subjects treated annually  

  2020cites this paper
• Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle

  2020cites this paper
• Cutaneous filariasis

  2020cites this paper
• Designing antifilarial drug trials using clinical trial simulators

  2020cites this paper
• Human Direct Skin Feeding Versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial)

  2019cites this paper
• Onchocerciasis Drug Discovery

  2019cites this paper
• Accelerating river blindness elimination by supplementing MDA with a vegetation “slash and clear” vector control strategy: a data-driven modeling analysis

  2019cites this paper
• Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol

  2019cites this paper
• Update on parasitic dermatoses

  2019cites this paper
• Efficacy and Safety of Ivermectin Against Trichuris trichiura in Preschool-aged and School-aged Children: A Randomized Controlled Dose-finding Trial

  2018cites this paper
• Neurological syndromes driven by postinfectious processes or unrecognized persistent infections

  2018cites this paper
• Anthelmintics in Dermatology

  2018cites this paper
• Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.

  2018cites this paper
• Pharmacokinetics‐Pharmacodynamics of High‐Dose Ivermectin with Dihydroartemisinin‐Piperaquine on Mosquitocidal Activity and QT‐Prolongation (IVERMAL)

  2018cites this paper
• Modelling the impact of mass administration of ivermectin in the treatment of onchocerciasis (river blindness)

  2018cites this paper
• Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness

  2017cites this paper
• Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal

  2017cites this paper
• Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial

  2017cites this paper
• Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles

  2017influential citation
• Neglected Tropical Diseases - Sub-Saharan Africa

  2016cites this paper
• Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings

  2016cites this paper
• Characterization of Onchocerca Volvulus Response to Ivermectin Treatment and Identification of Single Nucleotide Polymorphisms Associated With These Responses in Some Onchocerciasis Endemic Regions in Ghana

  2016cites this paper
• Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya

  2016cites this paper
• Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity

  2016cites this paper
• River Blindness: Mathematical Models for Control and Elimination.

  2016cites this paper
• Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus

  2016influential citation
• Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment

  2016cites this paper
• Host ABC transporter proteins may influence the efficacy of ivermectin and possibly have broader implications for the development of resistance in parasitic nematodes.

  2015cites this paper
• Microfilaridermia assessment of the efficacy of Ivermectin alone and Ivermectin plus Albendazole against Onchocerciasis

  2015cites this paper
• Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis

  2015cites this paper
• THE ARTHROPOD-BORNE ONCHOCERCIASIS: IS IT DESERVED TO BE NEGLECTED?.

  2015cites this paper
• Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa

  2014cites this paper
• 54 – The Filariases

  2014cites this paper
• Lymphatic and Tissue Filariasis

  2014cites this paper
• Chemotherapy in the treatment, control, and elimination of human onchocerciasis

  2014cites this paper
• Reproductive Status of Onchocerca volvulus after Ivermectin Treatment in an Ivermectin-Naïve and a Frequently Treated Population from Cameroon

  2014cites this paper
• Helminths: a clinical review and update.

  2014cites this paper
• Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment

  2014cites this paper
• Parasitological Responses of Onchocerca Volvulus to Ivermectin Treatment and Genetic Analysis of Beta Tubulin Gene

  2013cites this paper
• The impact and cost of ivermectin control strategies against River Blindness in Africa

  2013influential citation
• Chemotherapy of filariasis – established strategies and new developments

  2013cites this paper
• Dynamics of Onchocerca volvulus Microfilarial Densities after Ivermectin Treatment in an Ivermectin-naïve and a Multiply Treated Population from Cameroon

  2013cites this paper
• Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis

  2013cites this paper
• African Programme for Onchocerciasis Control 1995–2015: Model-Estimated Health Impact and Cost

  2013cites this paper
• Onchocerca volvulus-neurotransmitter tyramine is a biomarker for river blindness

  2013cites this paper
• Skin Tropical Infections and Dermatology in Travellers

  2013cites this paper
• P-Glycoprotein Genes in Haemonchus Contortus

  2013cites this paper
• Ivermectin in human medicine, an overview of the current status of its clinical applications.

  2012cites this paper
• Ivermectin: pharmacology and therapeutic applications

  2012cites this paper
• Observation of Elevated Air Pollutant Concentrations in a Residential Neighborhood of Los Angeles California Using a Mobile Platform.

  2012cites this paper
• Wolbachia endosymbiont of Onchocerca volvulus: driver of immunopathology and target for therapy

  2012cites this paper
• Single nucleotide polymorphisms in β-tubulin selected in Onchocerca volvulus following repeated ivermectin treatment: possible indication of resistance selection.

  2012cites this paper
• Ivermectin for onchocercal eye disease (river blindness).

  2012cites this paper
• Tuberculosis and Other Opportunistic Infections of the Genitourinary System

  2012cites this paper
• Measured and modeled variation in pollutant concentration near roadways

  2012cites this paper
• Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis

  2012cites this paper
• Resistance to macrocyclic lactones.

  2012cites this paper
• Importance of ivermectin to human onchocerciasis: past, present, and the future.

  2011cites this paper
• Phenotypic Evidence of Emerging Ivermectin Resistance in Onchocerca volvulus

  2011cites this paper
• The role of Brugia malayi ATP-binding cassette (ABC) transporters in potentiating drug sensitivity

  2011cites this paper
• ASSESSMENT OF THE EPIDEMIOLOGY OF ONCHOCERCA VOLVULUS AFTER TREATMENT WITH IVERMECTIN IN THE FEDERAL CAPITAL TERRITORY, ABUJA, NIGERIA

  2011cites this paper
• Ocular onchocerciasis: current management and future prospects

  2011cites this paper
• Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.

  2011cites this paper
• Facteurs influençant le phénotype de réponse d' Onchocerca volvulus à l'ivermectine

  2011influential citation
• Onchocerciasis in the Upper Imo River Basin, Nigeria: Prevalence and Comparative Study of Waist and Shoulder Snips from Mesoendemic Communities

  2010cites this paper
• Macrofilaricidal Activity after Doxycycline Only Treatment of Onchocerca volvulus in an Area of Loa loa Co-Endemicity: A Randomized Controlled Trial

  2010cites this paper
• 17 – Onchocerciasis and Other Parasitic Diseases

  2010cites this paper
• Agents Active against Parasites and Pneumocystis

  2010cites this paper
• Brugia malayi: in vitro effects of ivermectin and moxidectin on adults and microfilariae.

  2010cites this paper
• Unresolved issues in anthelmintic pharmacology for helminthiases of humans.

  2010cites this paper
• PROTOZOAN AND HELMINTHIC INFECTIONS

  2009cites this paper
• Onchocerciasis Control: Vision for the Future from a Ghanian perspective

  2009cites this paper
• A Wide Area of Air Pollutant Impact Downwind of a Freeway during Pre-Sunrise Hours.

  2009cites this paper
• Effects of Ivermectin with and without doxycycline on clinical symptoms of onchocerciasis.

  2009cites this paper